Obatoclax has been used in trials studying the treatment of AML, Leukemia, Myelofibrosis, Hodgkin's Lymphoma, and Mantle-Cell Lymphoma, among others.
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Lurie Children's Hospital-Chicago, Chicago, Illinois, United States
Indiana University Medical Center, Indianapolis, Indiana, United States
Mayo Clinic, Rochester, Minnesota, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
City of Hope Medical Center, Duarte, California, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, Maryland, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.